Immuno-oncology and Immunotherapy Part D

Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome “La Sapienza”. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology.Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals:OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience. Norma received her master’s degree in health biology from Paris Saclay. In 2013, she joined the laboratory of Dr. Guido Kroemer at the Centre de Recherche des Cordeliers (Paris, France) and at Gustave Roussy (Villejuif, France), the largest center for oncological patients in Europe. She worked on several projects linked to immunosurveillance, culminating with her obtaining her PhD in 2017 with an original work on “Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance”. She then moved to Weill Cornell Medicine to join the program in radiation and immunity under the mentorship of Dr. Galluzzi. Her current research is focused on investigating resistance to immunotherapy in a mouse model of HR+ breast cancer.Maud Charpentier received her M.Sc. in Cellular Biology and her Ph.D. in Immunology from the University of Nantes, France. She chose to pursue an academic career and continued her postdoctoral training in the United States. She joined the Department of Radiation Oncology at Weill Cornell Medicine under the mentorship of Dr. Sandra Demaria. Maud has a long-standing interest in the anti-tumor immune response and its role in controlling cancer progression and treatment outcomes. Her research focuses on understanding the synergy between radiation therapy and immunotherapy in solid tumors, with the aim of overcoming resistance to treatment and developing innovative therapeutic approaches in preclinical models.

• 1. Investigating the endothelial-immune axis in cancerGabriele Bergers and Kathryn A Kathryn A. Jacobs2. Establishing Tyro3, Axl, and Mertk Chinese Hamster Ovary (CHO) Reporter Cell Lines for Cancer Immunology and Therapeutic ApplicationsRaymond Birge3. Amino acid analog-based labelling of the immunomodulatory cancer secretomeKarin E. de Visser, Annemieke C. Bouwman, Antoinette van Weverwijk, Onno B. Bleijerveld, Liesbeth Hoekman, Bob J. Ignacio and Kimberly M. Bonger4. Human and mouse iNKT cell expansion and engineering with viral vectorsGloria Delfanti, Paolo Dellabona, Giulia Casorati and Michela Consonni5. Next-generation deconvolution of the tumor microenvironment with omnideconvFrancesca Finotello, Markus List, Alexander Dietrich and Lorenzo Merottto6. Comprehensive prediction of tumor neoantigens with NextNEOpiFrancesca Finotello, Dietmar Rieder and Markus Ausserhofer7. Ex vivo profiling of organotypic tumor spheroids in 3D microfluidic cultureRussell W. Jenkins8. A flow cytometry-based assay for evaluation of T cell activation and degranulation in coculture systemsAndreas Lunqdvist9. An adenosine production assay suitable for 2D and 3D cancer cell cultureAndreas Lunqdvist and Apple Tay Hui Min10. Determination of lactate in the tumor interstitial fluidSantos Manes, Ainhoa Ruíz-Iglesias, Angel García-Aldea, Elena Nonnast and Rosa M. Peregil11. Combined in vitro differentiation and cell sorting-based isolation of highly pure mouse bone marrow-derived basophils.Fabrizio Mattei and Giovanna Schiavoni12. Organ-on-Chip immunostaining method for three-dimensional identification and study of immune cells responding to drug-treated tumor cellsFabrizio Mattei, Giovanna Schiavoni, Francesco Noto, Adele De Ninno, Mario Falchi and Luca Businaro13. Evaluating transcriptional TME responses to immunotherapy using microarray analysisKaren Mossman14. Expansion and characterization of human peripheral blood derived NK cells for functional studies on tumour organoidsJulian Pardo Jimeno Sr. and ARIEL RAMIREZ LABRADA15. Inflammatory Neovascularization Analysis In Vivo in Matrigel Implants with Isolated IDVCs (IDO1-Dependent Vascularizing Cells)Alexander J. Muller, Souvik Dey, Arpita Mondal, James DuHadaway and Shih-Chun Shen16. Phenotypic assessment of dendritic cell maturation by cost-effective custom ELISA assaysPeng LIU, Guido Kroemer, Oliver Kepp and Liwei Zhao17. Pharmacological screening to identify potential regulators of antigen presentation by dendritic cellsPeng LIU, Liwei Zhao, Guido Kroemer, Oliver Kepp, Yuhong Pan and Shuai Zhang